(redirected from Gastroenteropancreatic Neuroendocrine tumor)
GEP-NETGastroenteropancreatic Neuroendocrine tumor
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Incidence of gastroenteropancreatic neuroendocrine tumors: a systematic review of the literature.
Molecular imaging of gastroenteropancreatic neuroendocrine tumors: current status and future directions.
Turkmen et al., "Can complementary 68Ga-dotatate and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?" Journal of Nuclear Medicine, vol.
Gastroenteropancreatic neuroendocrine tumors were detected in the stomach (n=15, 35.7%), appendix (n=11, 26.2%), rectum (n=6, 14.3%), pancreas (n=4, 9.5%), ileum and colon (n=2, 4.8%), and duodenum and jejunum (n=1, 2.4%).
Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumors. J Nucl Med.
Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors. PLoS ONE.
Tanaka et al., "Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan," Journal of Gastroenterology, vol.
Oberg, "Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors)," Current Opinion in Endocrinology, Diabetes and Obesity, vol.
Kim, "Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors," Gut and Liver, vol.
Table 1: World health organization classification of gastroenteropancreatic neuroendocrine tumors. Grade Origin Low <2 mitoses/10 HPFs and <3% Ki-67 index Intermediate 2-20 mitoses/10 HPFs or 3%-20% Ki-67 index High >20 mitoses/10 HPFs or >20% Ki-67 index HPF, high-power field.
Zou et al., "Multivariate analysis of metastasis-related risk factors for patients with gastroenteropancreatic neuroendocrine tumors based on clinicopathological and endoscopic features," Oncology Reports, vol.
ENETS consensus guidelines for the standards of care in neuroendocrine tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
Full browser ?